혼합 모드 크로마토그래피 용수지 시장

Global Mixed Mode Chromatography Resins Market to Reach US$153.7 Million by 2032

The global market for Mixed Mode Chromatography Resins estimated at US$96.2 Million in the year 2025, is expected to reach US$153.7 Million by 2032, growing at a CAGR of 6.9% over the analysis period 2025-2032. Ion Exchange - Hydrophobic Technique, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$80.0 Million by the end of the analysis period. Growth in the Hydroxyapatite Technique segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.1 Million While China is Forecast to Grow at 6.6% CAGR

The Mixed Mode Chromatography Resins market in the U.S. is estimated at US$28.1 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$27.2 Million by the year 2032 trailing a CAGR of 6.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Mixed Mode Chromatography Resins Market - Key Trends and Drivers Summarized

How Is Mixed Mode Chromatography Revolutionizing Biomolecule Separation?

Mixed mode chromatography resins are specialized materials used in the separation and purification of biomolecules, such as proteins, antibodies, and nucleic acids. These resins utilize a combination of different interaction modes, such as ion exchange, hydrophobic interaction, and affinity chromatography, to improve the efficiency and selectivity of the purification process. The adoption of mixed mode chromatography is gaining traction in the biopharmaceutical industry, where there is a growing need for high-purity and cost-effective separation techniques for complex biological products. The versatility of mixed mode chromatography resins makes them suitable for various applications, including the purification of monoclonal antibodies, recombinant proteins, and vaccine components. They are particularly valuable for purifying biomolecules that are challenging to separate using traditional single-mode chromatography techniques. The ability to achieve high resolution and selectivity in a single step can significantly reduce the number of purification steps required, thereby saving time and reducing costs.

What Innovations Are Shaping the Mixed Mode Chromatography Resins Market?

Several innovations are driving the development of mixed mode chromatography resins, including advances in resin design, enhanced ligand chemistry, and the incorporation of novel materials. Companies are focusing on developing resins that offer higher binding capacities and better selectivity for target molecules. The introduction of new ligands that can operate under a wider range of pH conditions and ionic strengths is expanding the applicability of mixed mode chromatography across different types of biomolecules. Automation and process control are also enhancing the adoption of mixed mode chromatography in industrial-scale purification. Automated chromatography systems can be programmed to optimize process parameters for specific resins, ensuring consistent and high-quality separations. The integration of continuous chromatography techniques, where mixed mode resins are used in continuous processing formats, is emerging as a trend in biomanufacturing, allowing for more efficient purification workflows.

How Do Market Segments Define the Growth of Mixed Mode Chromatography Resins?

Techniques include hydrophobic interaction, ion exchange, and multimodal chromatography, with multimodal chromatography being one of the most widely used due to its ability to combine different interaction mechanisms for improved selectivity. Applications encompass antibody purification, protein purification, and others, with antibody purification accounting for a significant market share due to the growing demand for monoclonal antibodies in therapeutic applications. End-users of mixed mode chromatography resins include biopharmaceutical companies, research institutions, and contract research organizations (CROs). Biopharmaceutical companies represent the largest end-user segment, driven by the need to improve purification processes and reduce manufacturing costs. Geographically, North America leads the market due to a strong presence of biopharmaceutical companies and advanced research infrastructure, while Asia-Pacific is experiencing rapid growth owing to increasing biopharmaceutical investments and research activities.

What Factors Are Driving the Growth in the Mixed Mode Chromatography Resins Market?

The growth in the mixed mode chromatography resins market is driven by several factors, including the increasing demand for biopharmaceuticals, the need for cost-effective purification techniques, and advancements in resin technology. As the biopharmaceutical industry expands, there is a growing need for high-purity separation techniques to produce therapeutic proteins, antibodies, and vaccines. The ability of mixed mode chromatography to simplify purification workflows and reduce the number of steps required is appealing to manufacturers looking to optimize production costs. Additionally, the development of novel resins with enhanced binding capacities and the integration of automation in chromatography processes are further propelling market growth.

SCOPE OF STUDY:

The report analyzes the Mixed Mode Chromatography Resins market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Ion Exchange - Hydrophobic, Hydroxyapatite, Other Techniques); Application (Polyclonal Antibodies, Non-Antibody Protein, Monoclonal Antibodies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

SELECT PLAYERS -

• Bio-Rad Laboratories
• Bio-Works Company Ltd.
• Danaher Corporation
• GE Healthcare Life Sciences
• JSR Micro Inc.
• Kaneka Corporation
• Knauer Gmbh
• Life Technology Corporation
• Merck
• Pall Corporation
• Purolite Corporation
• Sepragen Corporation
• Thermo Fisher Scientific
• Tosoh Corporation

WHAT SETS THIS REPORT APART FROM OTHERS?

Validated Sources - Human-curated validation and ranking of original source content, not AI LLM-generated synthetic content which dominates the internet today and has become a quick fix for most published research reports these days. Unlike most other published sources, our customers have access to full-stack source content. Our report draws from "real intelligence" balancing the power of AI against the risks of synthetically generated content and resulting biases. Customers have access to the source feeds.

Domain Expert Insights - Domain expert insights curated from enterprise, industry, academia, and government, consolidated from multilingual multimedia formats of text, voice, and images comprise a significant resource. Customers can request access to the pool of domain experts we track for this research project. We track 2,264 domain experts and their insights as part of this research project. Our customers may access our online tracker.

Annual subscription - Recommended for maximum value for your research dollar. Provides one additional full update during the 12 months and access to our research portal and interactive 10-user peer-to-peer collaboration drawing from our entire stack of validated project data which is updated on a weekly basis. Platform also enables adding enterprise data or third-party licensed content to build bespoke versions. Includes competitor tracking of up to 50 companies featured in the report.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Global Economic Update
  • Mixed Mode Chromatography Resins - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for High-Resolution Separation Techniques Spurs Growth in Mixed Mode Chromatography Resins Market
  • Technological Advancements in Resin Design and Functionalization Strengthen Business Case for Adoption
  • Growing Focus on Biopharmaceuticals and Protein Purification Expands Addressable Market for Chromatography Resins
  • Expansion of Mixed Mode Chromatography in Monoclonal Antibody (mAb) Production Fuels Market Growth
  • Increasing Adoption of Chromatography Resins in Viral and Gene Therapy Applications Expands Market Opportunities
  • Technological Innovations in High-Capacity and Selective Resins Propel Market Expansion
  • Rising Focus on Enhancing Purity and Yield in Downstream Processing Drives Demand for Chromatography Resins
  • Growing Use of Mixed Mode Chromatography in Analytical and Preparative Applications Expands Market Potential
  • Technological Advancements in Single-Use and Disposable Chromatography Systems Propel Market Growth
  • Rising Demand for Chromatography Resins in Continuous Processing and Perfusion Systems Strengthens Global Market
  • Expansion of Mixed Mode Chromatography in Food and Beverage Testing and Quality Control Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 2: World Historic Review for Mixed Mode Chromatography Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 3: World 13-Year Perspective for Mixed Mode Chromatography Resins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • TABLE 4: World Recent Past, Current & Future Analysis for Ion Exchange - Hydrophobic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 5: World Historic Review for Ion Exchange - Hydrophobic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 6: World 13-Year Perspective for Ion Exchange - Hydrophobic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • TABLE 7: World Recent Past, Current & Future Analysis for Hydroxyapatite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 8: World Historic Review for Hydroxyapatite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 9: World 13-Year Perspective for Hydroxyapatite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • TABLE 10: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 11: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 12: World 13-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • TABLE 13: World Recent Past, Current & Future Analysis for Polyclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 14: World Historic Review for Polyclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 15: World 13-Year Perspective for Polyclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • TABLE 16: World Recent Past, Current & Future Analysis for Non-Antibody Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 17: World Historic Review for Non-Antibody Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 18: World 13-Year Perspective for Non-Antibody Protein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • TABLE 19: World Recent Past, Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 20: World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 21: World 13-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • TABLE 22: World Mixed Mode Chromatography Resins Market Analysis of Annual Sales in US$ for Years 2020 through 2032

III. MARKET ANALYSIS

• UNITED STATES
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 24: USA Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 25: USA 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 26: USA Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 27: USA Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 28: USA 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 30: Canada Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 31: Canada 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 33: Canada Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 34: Canada 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• JAPAN
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 36: Japan Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 37: Japan 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 39: Japan Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 40: Japan 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• CHINA
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 42: China Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 43: China 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 44: China Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 45: China Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 46: China 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• EUROPE
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
  • TABLE 48: Europe Historic Review for Mixed Mode Chromatography Resins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 49: Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 51: Europe Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 52: Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 54: Europe Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 55: Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• FRANCE
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 57: France Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 58: France 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 59: France Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 60: France Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 61: France 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• GERMANY
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 63: Germany Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 64: Germany 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 66: Germany Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 67: Germany 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 69: Italy Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 70: Italy 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 72: Italy Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 73: Italy 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• UNITED KINGDOM
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 75: UK Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 76: UK 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 77: UK Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 78: UK Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 79: UK 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• REST OF EUROPE
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 81: Rest of Europe Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 82: Rest of Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 84: Rest of Europe Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 85: Rest of Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• ASIA-PACIFIC
  • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 87: Asia-Pacific Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 88: Asia-Pacific 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 90: Asia-Pacific Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 91: Asia-Pacific 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
• REST OF WORLD
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 93: Rest of World Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 94: Rest of World 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
  • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
  • TABLE 96: Rest of World Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
  • TABLE 97: Rest of World 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032

IV. COMPETITION